Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy.
Kong Y, Sheng X, Wu X, Yan J, Ma M, Yu J, Si L, Chi Z, Cui C, Dai J, Li Y, Yu H, Xu T, Tang H, Tang B, Mao L, Lian B, Wang X, Yan X, Li S, Guo J.
Kong Y, et al. Among authors: yan j, yan x.
Clin Cancer Res. 2017 Nov 15;23(22):6946-6957. doi: 10.1158/1078-0432.CCR-17-0070. Epub 2017 Aug 22.
Clin Cancer Res. 2017.
PMID: 28830923